ArticleRespirology case reports2024

Efficacy of tezepelumab against uncontrolled severe non-type 2 asthma refractory to bronchial thermoplasty, benralizumab, dupilumab and mepolizumab.

Yoshiro Kai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.